Nuburu shares jump 21.88% intraday as production starts for Ukraine GRAELION program with €5–10M revenue.
ByAinvest
Wednesday, Mar 18, 2026 1:00 pm ET1min read
BURU--
Nuburu surged 21.88% intraday following the announcement that its Ukraine initiative with Tekne and Beryl has entered production, marking a transition to revenue-generating activities. The GRAELION tactical prototype’s production launch, validated by Tekne on March 17, 2026, confirms €5–10M in Phase 1 revenue and provides visibility toward a scaled €80–120M program. This execution milestone, coupled with established supply chain validation and Ukrainian military deployment alignment, signals scalable defense demand. Nuburu’s equity stake in Tekne and integration of non-kinetic subsystems further underscore strategic value. The news directly aligns with the stock’s sharp intraday rise, reflecting investor confidence in transitioning from planning to operational execution in high-margin defense markets.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet